Effects of direct adsorption of lipoproteins apheresis on lipoproteins, low-density lipoprotein subtypes, and hemorheology in hypercholesterolemic patients with coronary artery disease

Therapeutic Apheresis

Volumn 6, Issue 2, 2002, Pages 130-135

  Otto, Carsten ^a   Geiss, H Christian ^a   Laubach, Ester ^a   Schwandt, Peter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Low density lipoprotein apheresis; Low density lipoprotein subfractions; Low density lipoprotein subtypes; Red cell deformability; Viscosity

Indexed keywords

C REACTIVE PROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADSORPTION; ADULT; APHERESIS; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEVICE; DISEASE SEVERITY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; PLASMA VISCOSITY; PRIORITY JOURNAL;

ABSORPTION; BLOOD COMPONENT REMOVAL; BLOOD VISCOSITY; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; CORONARY DISEASE; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FEMALE; HEMORHEOLOGY; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEIN(A); LIPOPROTEINS; MALE; MIDDLE AGED;

EID: 0036246333     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2002.00366.x     Document Type: Article

References (24)

1. Effect of statins on risk of coronary disease. A meta-analysis of randomized controlled trials
2. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III)
3. Safety and effectiveness of long-term LDL-apheresis in patients at high risk
4. Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemia
5. Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP)
6. Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment
7. Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans
8. Prospective randomized cross-over comparison of three LDL-apheresis systems in statin pre-treated patients with familial hypercholesterolemia
9. DALI The first human whole-blood low-density lipoprotein and lipoprotein(a) apheresis system in clinical use: Procedure and clinical results
10. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease
11. Plasma viscosity and the risk of coronary heart disease. Results from the MONICA-Augsburg Cohort Study. 1984 to 1992
12. Blood viscosity and risk of cardiovascular event: The Edinburgh Heart Study
13. Low-density lipoprotein subclass patterns and risk of myocardial infarction
14. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifugation
15. The shear stress diffractometer Rheodyn SSD for determination of erythrocyte deformability. I. Principles of operation and reproducibility
16. Low density lipoprotein hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI apheresis): Clinical experience from a single center
17. DALI apheresis in hyperlipidemic patients: Biocompatibility, efficacy, and selectivity of direct adsorption of lipoproteins from whole blood
18. Change in LDL particle size is associated with change in plasma triglyceride concentration
19. Fibrinogen, viscosity and the 10-year incidence of ischemic heart disease. The Caerphilly and Speedwell studies
20. Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies
21. Contribution of fibrinogen and lipoproteins to plasma viscosity in hypercholesterolemia and hypertriglyceridemia: Evaluation by selective depletion of low-density lipoproteins or fibrinogen
22. Increased plasma viscosity and erythrocyte aggregation: Indicators for an unfavourable clinical outcome in patients with unstable angina pectoris
23. The effects of fibrinogen and its plasmin degradation products on the rheology of erythrocyte suspensions
24. Erythrocyte membrane cholesterol/phospholipid changes and hemorheological modifications in familial hypercholesterolemia treated with lovastatin